Schomer 2018

Subscriber access provided by TUFTS UNIV
Article
Alanine scanning of YbdZ, an MbtH-like protein, reveals essential residues for
functional interactions with its nonribosomal peptide synthetase partner EntF
Rebecca A. Schomer, Hyunjun Park, John J. Barkei, and Michael George Thomas
Biochemistry, Just Accepted Manuscript • DOI: 10.1021/acs.biochem.8b00552 • Publication Date (Web): 19 Jun 2018
Downloaded from http://pubs.acs.org on June 21, 2018
Just Accepted
“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a service to the research community to expedite the dissemination
of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in
full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully
peer reviewed, but should not be considered the official version of record. They are citable by the
Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore,
the “Just Accepted” Web site may not include all articles that will be published in the journal. After
a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web
site and published as an ASAP article. Note that technical editing may introduce minor changes
to the manuscript text and/or graphics which could affect content, and all legal disclaimers and
ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or
consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W.,

Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the course
of their duties.
Page 1 of 41 Biochemistry
1
2
3
4 Alanine scanning of YbdZ, an MbtH-like protein, reveals essential
5
6
7 residues for functional interactions with its nonribosomal peptide
8
9
10 synthetase partner EntF
11
12
13
14
15
16 Rebecca A. Schomer, Hyunjun Park, John J. Barkei, and Michael G. Thomas*.
17
18
19 * Corresponding Author: michael.thomas@wisc.edu
20
21
22 Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, 53706.
23
24
25
26
KEYWORDS: Nonribosomal peptide synthetases, MbtH-like proteins, Natural Product
27
28 Biosynthesis, Nonribosomal peptides.
29
30
31 ABSTRACT.
32
33
34 Nonribosomal peptide synthetases (NRPSs) are megasynthetases that require complex and
35
36 specific interactions between multiple domains and proteins to functionally produce a metabolite.
37
38 MbtH-like proteins (MLPs) are integral components of many NRPSs and interact directly with
39
40
41
the adenylation domain of the megasynthetases to stimulate functional enzymology. All of the
42
43 MLP residues that are essential for functional interactions between the MLP and NRPS have yet
44
45 to be defined. Here we probe the interactions between YbdZ, an MLP, and EntF, an NRPS, from
46
47
Escherichia coli by performing a complete alanine and serine scan of YbdZ. A phenotypic
48
49
50 screen identified eleven YbdZ variants that are unable to replace the wild-type MLP, and these
51
52 YbdZ variants were characterized using a series of in vivo and in vitro assays in an effort to
53
54 explain why functional interactions with EntF were disrupted. All of the YbdZ variants enhanced
55
56
57
58
59 1
60 ACS Paragon Plus Environment
Biochemistry Page 2 of 41
1
2
3 the solubility of overproduced EntF, suggesting they were still capable of direct interactions with
4
5
6 the megasynthase. Conversely, we show that EntF also influences the solubility of YbdZ and its
7
8 variants. In vitro biochemical analyses of EntF function with each of the YbdZ variants found the
9
10 impact that an amino acid substitution will have on NRPS function is difficult to predict,
11
12
13
highlighting the complex interaction between these proteins.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59 2
1
2
3 Nonribosomal peptide synthetases (NRPSs) construct complex molecules via repetitive and
4
5
6 modular enzymology. Generally, one NRPS module incorporates one amino acid or aryl acid
7
8 into a nascent nonribosomal peptide (NRP) product. An NRPS module that initiates peptide
9
10 synthesis contains, at the minimum, an adenylation (A) domain that activates a specific starting
11
12
13
substrate and tethers it to a partner peptidyl carrier protein (PCP) domain to form an amino (or
14
15 aryl) acyl-S-PCP intermediate. Extending modules include a third domain, a condensation (C)
16
17 domain, which catalyzes amide bond formation between two PCP-linked intermediates to grow
18
19
the peptide in a directional manner. The terminal module commonly includes a thioesterase (Te)
20
21
22 domain that catalyzes the release of the final product by hydrolysis or cyclization. These four
23
24 domains are considered minimum scaffold upon which a NRPS is built.
25
26
27
28
29 Recently, our group1 and others2,3 discovered that there are two distinct classes of A domains
30
31 based on their requirement for an accessory protein. These accessory proteins are members of the
32
33 MbtH-like protein (MLP) superfamily. MLPs are relatively small proteins of approximately 60-
34
35
36
70 amino acids with three highly conserved tryptophan residues being the signature of this
37
38 protein family. These proteins are often encoded within the gene cluster that contains the MLP-
39
40 dependent NRPS genes,4,5 and to date these proteins have been found only in bacteria. For those
41
42
NRPSs that are MLP-dependent, the absence of this accessory protein has been observed to
43
44
45 result in a decrease in solubility of the NRPSs,1,2,6,7 an alteration in the kinetic parameters for
46
47 substrate activation,1,2,8,9 and significantly reduced catalytic turnover of the entire NRPS.10 MLPs
48
49 interact with the A domain of an NRPS, forming a 1:1 complex with this domain.1,3,11
50
51
52
53
54
55
56
57
58
59 3
1
2
3 Initial structural analysis of the isolated MLPs determined these proteins have a unique fold
4
5
6 consisting of a β-sheet formed by three β-strands followed by either one or two α-helices.12,13
7
8 While these structures did uncover the unique protein fold of MLPs, they did not provide clear
9
10 insights into how the MLPs influence NRPS enzymology. Interestingly, one of these structures
11
12
13 included electron density of an undefined molecule bound to the protein.13 This raised the
14
15 possibility that the MLPs may bind a small molecule that influences its function with the NRPS.
16
17 The first structure of an MLP/NRPS complex was of one of the few known proteins where the
18
19
20 MLP is fused to the N-terminus of its partner A domain.14 This structure identified the binding
21
22 site for the MLP on the A domain, which was far from the amino acid binding site. This
23
24 observation suggested MLPs must impart a conformational change in the partner A domain to
25
26
influence substrate binding. Finally, this structure provided some insights into why two
27
28
29 tryptophan residues are so highly conserved in MLPs. These two residues form part of a binding
30
31 pocket for an alanine residue from the A domain. Whether the other A domain is MLP-
32
33 dependent or not, the corresponding residue in other A domains is predominantly an alanine or a
34
35
36 proline residue. Gulick and colleagues subsequently extended the bioinformatic analysis of
37
38 MLP-dependent and independent A domains and these data suggest many NRPS A domains may
39
40 retain an ability to interact with partner MLP.9 Several other MLP/NRPS structures have been
41
42
43 solved.9,15–17. Gulick and colleagues were able to solve the structure of EntF, an NRPS involved
44
45 in the biosynthesis of the siderophore enterobactin by E. coli, with and without its MLP partner
46
47 YbdZ. Surprisingly, these two structures did not have significant conformational differences that
48
49
explained how MLPs increased NRPS solubility and adenylating activity.9,15 These structures
50
51
52 were solved using a substrate inhibitor, serine adenosine vinylsulfamide, (Ser-AVS), which
53
54 covalently links to the 4'-phosphopantethienyl arm of the PCP domain, trapping the NRPS in the
55
56
57
58
59 4
1
2
3 adenylating conformation. It is possible that use of this inhibitor limits our ability to capture EntF
4
5
6 in the less active state and that in solution EntF without YbdZ is found in multiple
7
8 conformational states. The finding that similar NRPS systems that are involved in the assembly
9
10 of the siderophore corynebactin (also known as bacillibactin) have altered apparent molecular
11
12
13
weights in the presence or absence of the partner MLP supports the hypothesis of an uncaptured
14
15 conformational state of the uncomplexed NRPS.16
16
17
18
19
In addition to structural analyses, several attempts to understand the role of the MLP using
20
21
22 mutational studies have been performed.1–3,8,14 The signature tryptophan residues of the MLP
23
24 were targeted by several groups. Felnagle et al. exchanged the signature tryptophan residue that
25
26 is not found in the tryptophan pocket with an alanine and phenylalanine residue.1 These residue
27
28
29 changes resulted in MLP variants that no longer co-purified with their NRPS partner and did not
30
31 confer functional activity to the A domain. Zhang et. al. targeted the tryptophan residues in the
32
33 structural tryptophan pocket.2 Exchanging one of the tryptophan residues with an alanine residue
34
35
36
resulted in a 50% reduction in A domain stimulation compared to the wild-type MLP. If both
37
38 tryptophan residues are replaced with alanines, the stimulatory effect of the MLP is abolished.
39
40 Herbst et al. examined the effect of altering the serine residue that falls in between the signature
41
42
tryptophans, observing that a tyrosine could not be accommodated at this site.14 To our
43
44
45 knowledge, only one study has attempted to target residues of the MLP that are not involved in
46
47 the tryptophan pocket.8 Garneau-Tsodikova and colleagues exchanged three highly conserved
48
49 prolyl residues with alanine residues individually and in pairs. They argued that the identity of
50
51
52 these residues is not critical for the MLP to stimulate A domain activity.
53
54
55
56
57
58
59 5
1
2
3 Despite the wealth of prior structural and biochemical data, researchers in the field have not
4
5
6 identified the physiologically essential residues of the MLP, nor a clearly defined the role the
7
8 conserved residues have in enabling the MLP to function. For such an evaluation, it is essential
9
10 to use a model NRPS system that provides the necessary in vivo and in vitro tools to dissect
11
12
13
MLP/NRPS interactions. The NRPS that produces the siderophore enterobactin (ENT) is such a
14
15 system. ENT is produced by Escherichia coli using an iterative, two-module NRPS that contains
16
17 one MLP-dependent A domain.1,18 This A domain is within the second module, which is
18
19
contained by the NRPS EntF (Fig. 1). An E. coli strain lacking ybdZ cannot grow in iron-limited
20
21
22 media (ILM) due to compromised production of ENT.1 This provides a simple in vivo means for
23
24 assessing physiologically relevant functions between YbdZ and EntF. We have also recently
25
26 shown we can reconstitute functional YbdZ/EntF complexes in vitro10 enabling us to dissect
27
28
29 these interactions and assess the function of the complex. Here we present a full alanine scan of
30
31 YbdZ and assess the function of protein variants using both in vivo and in vitro techniques.10,19–21
32
33 This work provides the most complete structure/function analysis of an MLP/NRPS complex to
34
35
36
date. Phenotypically, we identify 11 YbdZ variants that fail to replace YbdZ in vivo due to the
37
38 disruption of important MLP/NRPS interactions or destabilization of critical structural elements
39
40 of the MLP.
41
42
43
44
45
46
47
48
49
50
51 Fig. 1. Diagram of megasynthetase for ENT biosynthesis. This two-module NRPS acts
52
53 iteratively three times to generate one molecule of ENT.
54
55
56
57
58
59 6
1
2
3
4
5
6 Materials & Methods.
7
8 Generation of ybdZ mutants.
9
10 The ybdZ mutations were generated by PCR-based Quikchange site-directed mutagenesis of
11
12
13
pBAD33-ybdZ.1 The primers used to mutate the ybdZ codons are listed in Supplementary Table
14
15 1. All plasmids were sequenced to confirm the mutation and ensure no additional mutations were
16
17 generated by PCR amplification. All of plasmid constructs and strains used in this study are
18
19
listed in Supplementary Tables 2 and 3.
20
21
22
23
24 Assessing the in vivo function of ybdZ mutants.
25
26 Plasmids expressing the ybdZ mutants were transformed into the E. coli strain BW27749
27
28
29 ∆ybdZ.10 The resulting strains were assessed for growth in iron-limited media (ILM), which was
30
31 Teknova M9 minimal media supplemented with 0.4% v/v glycerol, 25 µM ethylenediamine-
32
33 N,N’-bis(2-hydroxyphenylacetic acid) (EDDHA) and 34 µg/mL chloramphenicol as previously
34
35
36
described.10 The final OD600 was recorded after 48 hrs of growth shaking at 200 rpm at 37°C.
37
38 Growth curves of select strains carrying ybdZ mutants were also performed in the presence or
39
40 absence of 0.001% w/v arabinose to the media as previously described.10
41
42
43
44
45 Co-overproduction of EntF with YbdZ and YbdZ variants for solubility assay.
46
47 BL21(DE3) ybdZ::acc(IV)1 was transformed with pTEV5-entF and pACYC-duet-1 containing
48
49 ybdZ or the ybdZ coding for the YbdZ variants: P6A, D8A, I16A, L17A, W27A, W37A, S48A,
50
51
52 L53A, A55S, P62A and Q69A. The genes coding for the YbdZ variants were cloned in a manner
53
54 that resulted in the production of un-tagged MLPs. Proteins were overproduced as previously
55
56
57
58
59 7
1
2
3 described10 and cells from 100 mL of each strain were harvested by centrifugation. These cells
4
5
6 were resuspended in 5 mL of 20 mM Tris-HCl (pH 8.0 at 4°C) with 300 mM NaCl and sonicated
7
8 on ice. BSA protein concentration assays were performed and compared to a standard curve to
9
10 quantify total protein in each cell-free lysate. Seventy-five micrograms of protein were run
11
12
13
separated by SDS-PAGE (10% polyacrylamide) and proteins were visualized by Coomassie blue
14
15 staining.
16
17
18
19
Detection of in vivo levels of YbdZ and EntF by immunoblotting.
20
21
22 A pBAD33 vector containing ybdZ or the ybdZ coding for the YbdZ variants P6A, D8A, I16A,
23
24 L17A, W27A, W37A, S48A, L53A, A55S, P62A and Q69A was transformed with pTEV5 or
25
26 pTEV5-entF into BW27749 ∆ybdZ. Each strain was then grown in Lysogeny Broth (LB)
27
28
29 containing 34 µg/mL chloramphenicol and 100 µg/mL ampicillin for 12 hours and then 100 µL
30
31 was subcultured into 3 mL of M9 minimal media containing 4% glycerol and both antibiotics.
32
33 When cultures reached an OD600 of 0.5, protein production was induced by adding 60 µM
34
35
36
isopropyl ß-D-1-thiogalacopyranoside (IPTG) or 0.001% w/v arabinose. Induced cultures were
37
38 incubated for 2 hours at 37°C before cells were harvested by centrifugation. Harvested cells were
39
40 treated with 100 µL 1X Bugbuster™ for each 100 µg of cell paste. After a ten-minute incubation
41
42
gently rocking at 25°C, samples were centrifuged at 16,100 x g for 5 min, generating cell free
43
44
45 extracts. Equal volumes of cell free extract were separated by SDS-PAGE (16.5% acrylamide)
46
47 and transferred to a PDVF membrane.10
48
49
50
51
52 The lysates of BL21(DE3) ybdZ::acc(IV) were also separated by SDS-PAGE (16.5%
53
54 acrylamide) and transferred to PDVF membrane as previously described.10 Membranes were
55
56
57
58
59 8
1
2
3 heated for 1 hour at 42°C until dehydrated and stored at 4°C for 16 hours. Membranes were then
4
5
6 rehydrated in phosphate buffer saline (PBS) pH 7.4 containing 1% (v/v) Tween-20 and 1:10,000
7
8 dilution of polyclonal antibody raised to YbdZ (Covance Inc.) for 1 hour at 25°C. Membranes
9
10 were washed for 5 minutes in PBS and 1% (v/v) Tween-20 before transfer into PBS pH7.4
11
12
13
containing 1% (v/v) Tween-20 and 1:10,000 dilution of goat anti-mouse-horseradish peroxidase
14
15 conjugate. Samples incubated in secondary antibody for 1 hour at 25°C. Membranes were
16
17 washed in 5 min intervals with PBS and exposed to Supersignal ® West Pico chemiluminescent
18
19
substrate (ThermoScientific).
20
21
22
23
24 In vitro assays.
25
26
27 EntF, EntF/YbdZ, holo-EntF, EntE, and EntB were overproduced and purified as previously
28
29 described.10 Overproduction of the EntF/I16A and EntF/P6A protein complexes followed the
30
31 same protocol as EntF/YbdZ, except that EntF/I16A and EntF/P6A were concentrated and flash
32
33
34
frozen in liquid N2 following the second Ni-NTA column and not taken through the final
35
36 purification step.10 All in vitro analyses of these proteins were performed as previously
37
38 described.10
39
40
41
42
43 Results & Discussion.
44
45 Eleven YbdZ variants are unable to complement for loss of wild-type YbdZ.
46
47 We were interested in determining the residues of an MLP that are essential for its functional
48
49
50 interactions with its NRPS partner. MLPs are relatively small proteins, making a full alanine and
51
52 serine scan of an MLP feasible. YbdZ was targeted for this approach due to the extensive in vivo
53
54 and in vitro techniques available to assess its functional interactions with EntF. Apart from the
55
56
57
58
59 9
1
2
3 starting methionine residue, each of the other 71 individual amino acid residues of YbdZ were
4
5
6 substituted with an alanine, with the exception that the seven naturally occurring alanine residues
7
8 were substituted with serine. Plasmids coding for these 71 YbdZ variants were introduced into
9
10 the E. coli strain BW27749 ∆ybdZ and the resulting strains were analyzed for growth in ILM,
11
12
13
providing an in vivo assessment of how well the variants replaced the wild-type YbdZ. The
14
15 strains were all tested in three biological replicates and the final OD600 was determined for each
16
17 strain after incubating at 37ºC for 48 hours. A comparison of the variants to an empty plasmid
18
19
control and a plasmid expressing the wild-type ybdZ found eleven YbdZ variants that failed to
20
21
22 reach a final OD600 above 0.4 (Fig. 2). These eleven variants were: P6A, D8A, I16A, L17A,
23
24 W27A, W37A, S48A, L53A, A55S, P62A and Q69A.
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59 10
1
2
3
Q72A
4 A71A
5 E70A
Q69A
6 L68A
Q67A
7 T66A
F65A
8 N64A
9 T63A
P62A
10 T61A
L60A
11 T59A
R58A
12 W57A
13 H56A
A55S
14 E54A
L53A
15 W52A
Q51A
16 Q50A
C49A
17 S48A
18 A47A
Q46A
19 S45A
Q44A
20 P43A
Q42A
21 C41A
22 V40A
I39A
23 D38A
W37A
24 G36A
A35S
25 P34A
26 L33A
V32A
27 C31A
Q30A
28 Q29A
P28A
29 W27A
30 L26A
S25A
31 F24A
Q23A
32 G22A
Q21A
33 A20S
34 N19A
R18A
35 L17A
I16A
36 Y15A
F14A
37 A13S
G12A
38 Q11A
39 P10A
D9A
40 D8A
F7A
41 P6A
N5A
42 S4A
43 F3A
A2S
44 YbdZ
EV
45
46
0
2
0.
0.
0.
0.
0.
1.
1.
47
OD600
48
49
50 Fig. 2. Analysis of complementation of BW27749 ∆ybdZ by YbdZ alanine variants. Data shown
51
is the final OD600 after 48 hours of growth in ILM. Variants that reached an OD600 of 0.4 or
52
53 lower are highlighted in red. Data are shown as mean of triplicate biological replicates with
54 standard deviation. Abbreviations: EV, empty vector; YbdZ, wild-type protein.
55
56
57
58
59 11
1
2
3 Amino acid substitutions that that disrupt YbdZ function map to variety of locations on the YbdZ
4
5
6 structure.
7
8 Using the co-structure of EntF and YbdZ,9 we mapped the residues identified in the functional
9
10 screen to generate hypotheses for why each residue substitution resulted in a nonfunctional or
11
12
13
poorly functional MLP. All the residues of interest were present in the available structure with
14
15 the exception of Q69, which mapped to region of the protein that was unresolved in the crystal
16
17 structure. Our previous observations proposed that overall topology of the MLP interface was
18
19
critical in forming functional interactions between the MLP and NRPS.10 Based on that
20
21
22 hypothesis, we anticipated that most of the residues found using our in vivo screen would be
23
24 found on the surface of YbdZ that interacts directly with the A domain.9 Consistent with this,
25
26 seven of the eleven residues (P6, D8, L17, W27, W37, L53, and P62) mapped to the interface
27
28
29 between the EntF A domain and the MLP (Fig. 3A.) Surprisingly, two of the residues (S48 and
30
31 A55) mapped to the surface of YbdZ opposite from EntF, while the two remaining residues (L17
32
33 and L53) are located in an internal region of the protein. Many of the residues we found to be
34
35
36
conserved in ≥ 90% of MLPs from a database of 5,393 MLPs found in GenBank10 were not
37
38 identified in our screen and may have greater flexibility than conservation might imply (Fig. 3B).
39
40
41
42
Using the structure as a guide, we began to develop hypotheses for why each amino acid
43
44
45 substitution resulted in decreased YbdZ function. Proline 6 is part of an N-terminal α-helix-like
46
47 structural component that packs into a cleft of the EntF A domain (Fig. S1A). Replacement of
48
49
50
this prolyl residue with an alanine may alter the packing of this α-helix-like structure into the
51
52 cleft, disrupting or altering the YbdZ/EntF interactions. Aspartate 8 forms ionic interactions with
53
54 R836 of the conserved A7 motif of the A domain (Fig. S1B). Disruption of this ionic interaction
55
56
57
58
59 12
1
2
3 may result in a reduced affinity between EntF and YbdZ. Tryptophan 27, W37 and L17 form a
4
5
6 small pocket on the MLP that interacts with A825 of EntF (Fig. S1C). This pocket has been
7
8 implicated as critical in MLP/NRPS interactions, consistent with earlier mutagenesis studies that
9
10 found substitutions to either tryptophan residue disrupts MLP function.14,22 Our finding that an
11
12
13
amino acid substitution of a third residue of this pocket disrupts MLP function extends the
14
15 importance of this structural component. Surprisingly, the third signature conserved tryptophan
16
17 residue, W57, which is involved in nonpolar interactions with the A domain, was not found to be
18
19
20
essential using our phenotypic screen. Instead, the residue immediately above W57 in an α-helix,
21
22 L53, was identified. L53 and the internal residue I16 appear to contribute significantly to the
23
24 structure of YbdZ (Fig. S1E). We hypothesize that these residues play a role in correctly
25
26
positioning the pocket composed of L17-W27-W37 by occupying essential structural space in
27
28
29 the protein directly behind this feature (Fig. S2A). Proline 62 is located in a C-terminal α helix
30
31 that interacts with the A domain signature sequence A3 of EntF (Fig. S1E). We predict that if
32
33 Q69 had been resolved in this MLP structure it would be found in this structural element as well.
34
35
36 Interestingly, this is the only region on the EntF/YbdZ and EntF/PA2412 co-structures that do
37
38 not align (Fig. S2B). Many structural studies have identified that the C-terminal regions of MLPs
39
40 are highly dynamic.9,12,13 Disruption of this helix could alter functional interaction. These
41
42
43 differences seen in the primary structure and orientation of the C-terminus are a strong candidate
44
45 for variation in MLP specificity for its partner NRPS. Lastly, the final two residues identified
46
47 from the growth screen, S48 and A55, map to the surface of the MLP that faces away from the
48
49
NRPS (Fig. 3A). The presence of these residues on the outward face of the MLP raise questions
50
51
52 about the possibility of the MLP binding a small molecule or an alternate protein partner.
53
54
55
56
57
58
59 13
1
2
3 The structural analyses of EntF and EntF/YbdZ did not show any distinct conformational
4
5
6 changes upon the binding of YbdZ.9,15 Because the enzyme must be captured for crystallography
7
8 using the inhibitor Ser-AVS, it is likely that trapping the enzyme with this inhibitor locks EntF
9
10 into the same conformation even if physiologically conformational changes occur with MLP-
11
12
13
binding. Unfortunately, due to the lack of informative differences between the two structures, it
14
15 is difficult to ascertain why the residues we identified phenotypically are not capable of
16
17 influencing NRPS enzymology like the wild-type YbdZ using the structural data available.
18
19
Therefore, we proceeded to characterize the influence of the YbdZ variants using
20
21
22 immunoblotting and biochemical assays to further understand their decreased functionality in
23
24 vivo and test the hypotheses noted above for explaining why the amino acid substitutions
25
26 disrupted YbdZ function. For the remainder of this work, we will refer to each YbdZ variant
27
28
29 protein by the position of the alanine or serine exchange it contains. For example, the YbdZ
30
31 variant protein containing a P6A exchange will be referred to as P6A.
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52 Fig. 3. (A) Surface renderings of YbdZ (blue) structure in complex with EntF (yellow). The
53 outward facing surface of YbdZ (left) and inward facing surface (right) contain most of the
54 residues of interest (red) that result in a growth defect when altered. (B) Amino acid sequence of
55 YbdZ. Underlined residues are on the interface between YbdZ and EntF, starred residues are
56
57
58
59 14
1
2
3 highly conserved across MLP superfamily (≥90% conservation across 5,393 unique predicted
4
MLPs from GenBank) and the residues of interest from the growth screen are highlighted in red.
5
6
7
8 Analysis of the in vivo levels of the YbdZ variants.
9
10 To begin investigating why these YbdZ variants fail to fully replace the wild-type YbdZ, the in
11
12
13
vivo level of each variant was analyzed using immunoblotting with polyclonal antibodies raised
14
15 against YbdZ. Basal levels of expression from the pBAD promoter were sufficient for in vivo
16
17 complementation by wild-type YbdZ, but these levels were not sufficient for protein detection by
18
19
YbdZ-specific polyclonal antibodies using immunoblotting (Fig. S3). Increasing the expression
20
21
22 of ybdZ from the pBAD promoter by adding arabinose to the culture medium did enable
23
24 detection of YbdZ (Fig. S3). Using this induction condition, the in vivo level of each YbdZ
25
26 variant was assessed and compared to wild-type YbdZ (Fig. 4). From this analysis, only D8A
27
28
29 was found to be present at levels similar to those observed for wild-type YbdZ. The other YbdZ
30
31 variants had significantly reduced or undetectable levels of protein. These data suggest that the
32
33 stability of nearly all of the YbdZ variants was compromised by the amino acid substitution each
34
35
36
carries.
37
38
39
40 Increased levels of EntF result in increased levels of detectable YbdZ and YbdZ variants.
41
42
The decreased levels of the YbdZ variants compared to the wild-type YbdZ suggested that the
43
44
45 instability of these proteins might explain why they failed to functionally replace the wild-type
46
47 protein. However, when the expression of the variants was induced, it was reasonable to assume
48
49 the MLPs were in excess relative to the levels of EntF in the cell. It was possible that the YbdZ
50
51
52 variants were less stable than the wild-type enzyme because the majority of the protein being
53
54 detected by immunoblotting was not complexed with EntF. To date, MLPs have been evaluated
55
56
57
58
59 15
1
2
3 for their ability to influence the solubility of an NRPS, but the converse has not been
4
5
6 investigated. To address this issue, we introduced a plasmid expressing entF into the strains
7
8 expressing ybdZ or ybdZ variants and assessed whether the presence of increased levels of EntF
9
10 influenced the detectable levels of the MLPs. Using the wild-type YbdZ as a starting point,
11
12
13
increasing the levels of EntF in the cell resulted in increased levels of detectable YbdZ. This is
14
15 the first evidence that the stability of an MLP can be influenced by its partner NRPS. Similar
16
17 analyses of the YbdZ variants showed that increased levels of EntF resulted in detectable levels
18
19
of nine of the eleven YbdZ variants (Fig. 4). Regardless of whether excess EntF was present or
20
21
22 not, neither P6A nor I16A were detectable suggesting these MLPs are very unstable in vivo and
23
24 explains why they fail to functionally replace YbdZ. Similarly, Q69A was barely detectable in
25
26 the presence of increased levels of EntF and was likely to be too unstable in vivo to functionally
27
28
29 replace wild-type YbdZ. In contrast, eight of the YbdZ variants were detected at levels
30
31 comparable to the wild-type YbdZ when EntF levels were increased. These data suggest these
32
33 YbdZ variants were competent for interacting with EntF and these interactions stabilize these
34
35
36
MLPs to levels comparable to wild-type YbdZ.
37
38
39
40 We note that repeated attempts to detect the levels of chromosomally encoded EntF using
41
42
immunoblotting all failed. For these attempts, chromosomal entF was modified to code for an
43
44
45 EntF variant with a C-terminal HA or T7 tag to enable the use of commercially available
46
47 monoclonal antibodies to these tags. Surprisingly, E. coli strains producing these tagged EntF
48
49 variants had a growth defect in ILM, suggesting the C-terminal tagging of EntF somehow
50
51
52 disrupts ENT production. Attempts to use a plasmid coding for an N-terminal His-tagged EntF
53
54 did enable the detection of EntF, but only when the levels of induced EntF were increased to the
55
56
57
58
59 16
1
2
3 point that the protein could also be observed by SDS-PAGE/Coomassie blue staining. Due to
4
5
6 these detection limitations, we did not make further attempts to analyze the in vivo EntF levels to
7
8 complement the studies analyzing the in vivo levels of YbdZ. The impact the YbdZ variants had
9
10 on the level of soluble EntF when the NRPS is overproduced with these different MLPs was
11
12
13
evaluated and is discussed in a later section.
14
15
16
17 Increased expression of the ybdZ variants does not enable full complementation of a ∆ybdZ
18
19
strain.
20
21
22 Based on the finding that most of the YbdZ variants were at lower levels in the cell compared to
23
24 wild-type YbdZ, but when complexed with EntF their levels were comparable to the wild-type
25
26 MLP, the in vivo complementation was re-evaluated using the arabinose induction conditions.
27
28
29 We reasoned that by increasing the levels of the YbdZ variants in the cell, the level of YbdZ
30
31 variant/EntF complexes would be enhanced, possibly improving their ability to functionally
32
33 replace wild-type YbdZ. Three of the YbdZ variants showed improvements in complementation
34
35
36
by increasing the expression of the corresponding genes (W27A, W37A, and Q69A) (Fig. S4).
37
38 Even with these improvements in ENT production for the W27A, W37A, and Q69A variants,
39
40 none of them complemented near the levels seen with wild-type YbdZ. There were two variants
41
42
(P6A and A55S) where induction slightly reduced the low level of complementation. Based on
43
44
45 these complex in vivo results, we turned to more in vitro studies to gain additional insights into
46
47 the reason for many of these variants having the observed phenotypes.
48
49
50
51
52 The YbdZ variants increase the solubility of overproduced EntF.
53
54
55
56
57
58
59 17
1
2
3 We have shown that the amount of soluble EntF overproduced in E. coli BL21(DE3)
4
5
6 ybdZ::aac(3)IV is significantly enhanced when YbdZ is co-overproduced.1,10 The same solubility
7
8 experiments were performed with each of the YbdZ variants. Surprisingly, even though these
9
10 YbdZ variants were identified because they failed to functionally replace the wild-type MLP in
11
12
13
vivo, they all enabled overproduced EntF to be significantly more soluble than observed when
14
15 EntF is overproduced in the absence of an MLP (Fig. 5A). These data support our prior finding
16
17 that solubility and function are separable.10
18
19
20
21
22 It was unexpected that P6A and I16A positively influenced EntF solubility since we failed to
23
24 detect these variants by immunoblotting even when EntF levels were increased (Fig. 4). We
25
26 decided to investigate whether these, and the other YbdZ variants, were detectable in these
27
28
29 overproducing strains using the same polyclonal antibodies discussed above for immunoblotting
30
31 (Fig. 5B). When overproduced, P6A was detected at levels very similar to the wild-type YbdZ.
32
33 At this time is not clear why there is such a difference between these observations in E. coli
34
35
36
BL21(DE3) and BW27749 ∆ybdZ. The more unusual finding was I16A remained undetectable
37
38 by immunoblotting but did enable overproduced EntF to be soluble at levels comparable to the
39
40 presence of the wild-type YbdZ. Further investigations into the failure to detect I16A are
41
42
discussed in a later section.
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59 18
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19 Fig. 4. Representative immunoblots for the assessment of YbdZ and variants levels in the
20 presence and absence of EntF in BW27749 ∆ybdZ.
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
Fig. 5. Top: Analysis of levels of overproduced EntF in the presence of YbdZ variants. Bottom:
39
40
Immunoblot of analysis of YbdZ variant levels when overproduced with EntF in BL21(DE3)
41 ybdZ::acc(IV).
42
43
44 Determining the Kd of EntF for the YbdZ variants.
45
46
At this point in our study, the data indicated that the YbdZ variants were interacting with EntF in
47
48
49 vivo as YbdZ variant or EntF levels are increased in the presence of their partner protein. To gain
50
51 additional insight about how these nonfunctional variants interact with EntF, we aimed to
52
53 characterize the influence of each variant on the adenylation activity of EntF in vitro.
54
55
56
57
58
59 19
1
2
3 To be consistent with our previous report,10 we will refer to EntF purified alone as EntF, EntF
4
5
6 co-purified with YbdZ as EntF/YbdZ and a reconstituted complex of individually purified EntF
7
8 and YbdZ as EntF+YbdZ. EntF has an affinity for L-Ser that is 10-fold lower than EntF/YbdZ
9
10 and EntF+YbdZ1,10 (Table 1). Previously, we showed that by adding a gradient of exogenously
11
12
13
purified MLP back to EntF, we can determine the binding affinity Kd of EntF for the MLP using
14
15 ATP-PPi exchange assays and Michaelis-Menton kinetics.10 Once the Kd of EntF for a specific
16
17 MLP is determined, excess MLP can be added and an affinity of the EntF+MLP complex for L-
18
19
Ser can be assessed.10
20
21
22
23
24 We overproduced and purified each YbdZ variants with the exception P6A, which we could not
25
26 isolate in the absence of its EntF partner. Surprisingly, we were able to isolate I16A, which was
27
28
29 not detected by antibody even when co-overproduced with EntF in the BL21(DE3)
30
31 ybdZ::acc(IV) strain (Figs. 4 and 5). To determine if the variation EntF affinity for each YbdZ
32
33 variant correlated with the reduced in vivo complementation by each mutant, we determined the
34
35
36
Kd of EntF for each YbdZ variant. Notably, three of the variants, D8A, W27A and W37A, have a
37
38 Kd that is significantly higher in comparison to WT YbdZ. For these three variants, it is likely
39
40 that, in addition to lower protein levels (Fig. 4), the reduced ability to interact with EntF
41
42
compromises the ability of these MLPs to complement for the loss of YbdZ (Fig. 1). Consistent
43
44
45 with this, EntF has the highest Kd for W37A and this variant increases the solubility of EntF at a
46
47 noticeably reduced level (Fig. 5A). This aligns with previous observations that noncognate MLPs
48
49 with increased Kd for EntF sometimes have a reduced influence on NRPS solubility.10 The
50
51
52 remaining variants had either unaffected or slightly impaired Kd in comparison to YbdZ, showing
53
54
55
56
57
58
59 20
1
2
3 that EntF has a similar affinity for each of these variants, but these complexes are functionally
4
5
6 different.
7
8
9
10 L-Ser activation by the EntF+YbdZ variants:
11
12
13
To parse apart whether these YbdZ variants fail to replace YbdZ in vivo was due to an altered
14
15 affinity of EntF for L-Ser while complexed with these YbdZ variants, the Km for L-Ser for each
16
17 reconstituted NRPS/MLP complex was determined. Our previous study of noncognate MLPs
18
19
observed that a noncognate MLP was capable of in vivo complementation despite a doubling of
20
21
22 the Km for L-Ser that led to a 2-fold reduction in kcat/Km compared to the cognate MLP.10
23
24 Noncognate MLPs that had a kcat/Km that was less than half that of EntF+YbdZ were not capable
25
26 of in vivo complementation. Similar analyses of these kinetic parameters were performed on
27
28
29 EntF with the YbdZ variants in this study. With the exception of EntF+W27A, all of the tested
30
31 EntF+YbdZ variant complexes have increased Km compared to EntF (Table 1). EntF+W27A is
32
33 similar to EntF lacking an YbdZ partner, aligning with previous results that this highly conserved
34
35
36
residue is critical for MLP function.2 EntF+I16A, EntF+W37A, EntF+S48A, EntF+L53A and
37
38 EntF+A55S have a Km for L-Ser that is more than double the Km observed for the EntF+YbdZ
39
40 complex, resulting in turnover rates that are less than half of EntF+YbdZ. These data led to the
41
42
conclusion that these residue changes fail to enhance the function of EntF significantly enough to
43
44
45 allow growth in ILM.
46
47
48
49 For the remaining YbdZ variants, several altered EntF kinetics for L-Ser activation in a similar
50
51
52 manner to the noncognate MLPs that could functionally replace YbdZ in vivo. EntF+D8A,
53
54 EntF+L17A, EntF+P62A, and EntF+Q69A all have approximately two-fold weaker affinity for
55
56
57
58
59 21
1
2
3 L-Ser compared to EntF+YbdZ. The kinetic parameters of these complexes are more similar to
4
5
6 EntF+YbdZ than those found for the functional noncognate complexes, EntF+MbtH,
7
8 EntF+PA2412, EntF+MXAN_3118 and EntF/Atu3678.10 This level of reduction of Km was
9
10 shown to be an insufficient alteration of the EntF enzymology to result in a growth deficiency,
11
12
13
implying the mechanism of failure for these variants is likely not due to defects in L-Ser
14
15 activation. The Q69A levels are clearly compromised in relation to YbdZ both in the presence
16
17 and absence of EntF; therefore, it is likely that reduced levels of this YbdZ variant are
18
19
responsible for its inability to replace YbdZ in vivo. The reduction of L17A and P62A levels
20
21
22 does not appear as severe as the reduced levels of Q69A, while D8A was the only variant we
23
24 observed that maintained protein levels similar to YbdZ under all conditions (Figs. 4 and 5). It is
25
26 possible these three YbdZ variants are either failing to fulfill alternative functions of YbdZ in
27
28
29 ENT biosynthesis or negatively influencing an additional step in NRPS enzymology.
30
31
32
33 Table 1. Kinetic parameters of EntF with YbdZ variantsa.
34
35
Protein: Kd (nM) Km (uM Ser) kcat(s-1) kcat/Km(M-1s-1)
36
37 EntF - 1029 ± 171 0.84 ± 0.050 816
38
39 EntF + WT YbdZ 186 ± 69 116 ± 22 0.88 ± 0.04 7858
40
41 EntF + D8A YbdZ 555 ± 150 279 ± 59 0.97 ± 0.08 3476
42
43 EntF + I16A YbdZ 109 ± 27 430 ± 83 1.26 ± 0.11 2930
44
45 EntF + L17A YbdZ 295 ± 88 159 ± 32 0.93 ± 0.05 5849
46
47 EntF + W27A YbdZ 636 ± 78 1013 ± 143 0.98 ± 0.07 848
48
49 EntF + W37A YbdZ 1177 ± 338 438 ± 130 1.1 ± 0.11 2255
50
51 EntF + S48A YbdZ 41 ± 10 451 ± 59 1.14 ± 0.72 2527
52
53 EntF + L53A YbdZ 213 ±100 453 ± 92 1.29 ± 0.13 2847
54
55 EntF + A55S YbdZ 270 ± 88 450 ± 80 1.01 ± 0.08 2244
56
57
58
59 22
1
2
3 EntF + P62A YbdZ 229 ± 85 297 ± 60 1.21 ± 0.10 4074
4
5 EntF + Q69A YbdZ 374 ± 130 208 ± 74 0.94 ± 0.11 4519
6
7 EntF/P6A - 382 ± 59 0.93 ± 0.04 2434
8
9 EntF/I16A - 129 ± 34 0.78 ± 0.04 5736
10
11 EntF + MbtH10 54.6 ± 8 229 ± 31 0.74 ± 0.04 3231
12
13 EntF + PA241210 358 ± 95 397 ± 94 1.21 ± 0.06 3047
14
15 a
Data shown in graphical form in Figs. S5 and S6.
16
17
18
19
20 D8A, L17A and P62A can efficiently replace YbdZ for in vitro ENT production.
21
22 Prior work has shown that even when the affinity of EntF for L-Ser is compensated for by adding
23
24 an excess concentration of L-Ser, ENT assembly is still compromised, suggesting YbdZ
25
26
27 influences more than just amino acid binding by EntF.10 Using the same in vitro ENT
28
29 biosynthesis reconstitution assays, we probed whether D8A, L17A and P62A influenced ENT
30
31 production like wild-type YbdZ. While these variants influenced EntF affinity for L-Ser, we
32
33
34
hypothesized they may be unable to fulfill alternate functions of YbdZ in ENT biosynthesis.
35
36 However, in the presence of all three of these YbdZ variants, ENT is produced at levels similar
37
38 to when wild-type YbdZ is present (Fig. 6). These data suggest that the decreased in vivo levels
39
40
of L17A and P62A were the primary cause for their inability to replace YbdZ in vivo (Figs. 1 and
41
42
43 4). Reduced solubility does not account for the inability of D8A to replace WT YbdZ, rather the
44
45 increased Kd of EntF for the D8A is the only parameter we identified that is interfering with the
46
47 functionality of this YbdZ variant. When D8A levels are increased in vitro to account for the
48
49
50 decreased affinity of EntF for D8A, the EntF+D8A complex has kinetic parameters similar to
51
52 WT YbdZ (Table 1). Clearly, increased expression of D8A did not result in increased levels of
53
54 D8A to compensate for the affinity difference in vivo.
55
56
57
58
59 23
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Fig. 6. In vitro ENT production in the presence of several YbdZ variants monitored by CAS
21
22 absorbance.
23
24
25 Co-production of EntF with I16A and P6A influences EntF adenylation activity.
26
27 Since we could not visualize or isolate P6A without coproduction of EntF, we co-overproduced
28
29
30 EntF and P6A and attempted to purify the EntF/P6A complex to evaluate how this YbdZ variant
31
32 influences EntF activity. Additionally, the odd observation that I16A was not detected by
33
34 immunoblotting even though it enhanced over-produced EntF solubility and that we were able to
35
36
37 overproduce and purify I16A led us to co-overproduce EntF/I16A and attempt to purify the
38
39 complex to evaluate EntF activity.
40
41
42
43
Purification of EntF that was co-overproduced with YbdZ P6A followed by SDS-
44
45
46 PAGE/Coomassie blue staining determined that these proteins did not co-purify in the usual ratio
47
48 of approximately 1:11,3,11 (Fig. S7). The EntF/P6A complex had to be concentrated to detect
49
50 minimal quantities of P6A, leading us to conclude that only a small population of this EntF is
51
52
53 complexed with P6A. These data suggest that while this YbdZ variant can interact with EntF
54
55 and enhance its solubility, the affinity of EntF for YbdZ P6A must not be strong enough for the
56
57
58
59 24
1
2
3 majority to survive purification in a typical ratio. In contrast, EntF and YbdZ I16A did co-purify
4
5
6 (Fig. S7). This finding suggests the amino acid substitution abolishes the recognition site of the
7
8 antibody, making it undetectable by immunoblotting.
9
10
11
12
13
The kinetic parameters for L-Ser activation by EntF co-overproduced with P6A and EntF/I16A
14
15 were determined (Table 1). Even though the EntF co-produced with P6A lost much of the MLP
16
17 after purification, the kinetics of L-Ser activation were improved relative to EntF purified in the
18
19
absence of YbdZ. These results suggest that P6A influenced the conformation of EntF, and this
20
21
22 altered form of EntF was retained even after the MLP disassociated from the NRPS. When
23
24 EntF/I16A was assayed for L-Ser affinity, the kinetics for L-Ser activation were quite similar to
25
26 those observed for EntF+YbdZ. However, when we added the EntF/I16A to our in vitro ENT
27
28
29 biosynthesis reconstitution assay, it was severely defective in producing ENT (Fig. 7). These
30
31 data suggest that while YbdZ I16A is holding EntF in a more soluble and active conformation for
32
33 adenylation activity, it fails to hold EntF in a conformation that is compatible with overall
34
35
36
function of the NRPS.
37
38
39
40 It is important to note that while the addition of exogenously produced YbdZ to EntF fully
41
42
restores the adenylation activity to levels of EntF/YbdZ,10 the Km of EntF/I16A for L-Ser and Km
43
44
45 of EntF+I16A for L-Ser are quite different. This is likely due to the presence of EntF influencing
46
47 the solubility of YbdZ (Fig. 4). This complicates our ability to extract physiologically relevant
48
49 data from characterization of separately purified and recapitulated MLP/NRPS complexes. While
50
51
52 co-production allows us to bypass the issue of misfolded MLPs or NRPSs to some extent, one
53
54 issue with the analysis of co-purified MLP/NRPS complexes is that they vary in levels of MLP-
55
56
57
58
59 25
1
2
3 bound and unbound NRPS, as observed in the overproduction and purification of EntF in the
4
5
6 presence of YbdZ P6A or YbdZ I16A (Fig. S7). The complexity of the interdependence of the
7
8 NRPS and MLP for one another makes these interactions challenging to disentangle. Thus,
9
10 conclusions drawn from a combination of in vivo and in vitro analyses of any NRPS/MLP
11
12
13
interactions are likely to be more informative.
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31 Fig. 7. Detection of ENT production by reconstituted ENT biosynthetic system in the presence of
32 EntF, EntF/YbdZ and EntF/I16A as detected by CAS after 80 minutes at 37°C. Each reaction
33 was run in triplicate and standard error is shown. Statistic analyses indicated EntF/I16A was
34
statistically different from EntF (p=0.0009) and EntF/YbdZ (p<0.0001).
35
36
37
38 Conclusions.
39
40 In summary, we identified 11 residues in YbdZ that influenced the ability of this MLP to have
41
42
functional in vivo interactions with EntF. We found no evidence of a single catalytic residue or
43
44
45 of a small molecule binding pocket using this functional screen. Rather, the amino acid
46
47 substitution scan indicated several structural elements of the MLP that are important for
48
49 functional interactions or MLP stability. In particular, the N-terminal region, an alanine-binding
50
51
52 pocket, and the C-terminal helix were identified as important structural features. P6A and D8A
53
54 of the N-terminal region have compromised interactions with EntF as seen by an inability to co-
55
56
57
58
59 26
1
2
3 purify with EntF and a reduced Kd respectively, indicating this region as important in
4
5
6 MLP/NRPS affinity for one another. Variants that disrupt the binding pocket for A825 of EntF
7
8 (L17A, W27A, W37A) or that potentially disrupt the coordination of this binding pocket (I16A
9
10 and L53A) have reduced stability as well as a variety of functional incompatibilities in vitro.
11
12
13
This pocket that has been targeted repeatedly for mutagenesis is obviously functionally relevant
14
15 to the MLP/NRPS complex. Finally, variants that disrupted the C-terminal helix region (P62A,
16
17 Q69A) have reduced in vivo levels, but were able to stimulate EntF activity nearly as well as
18
19
YbdZ in vitro, indicating that this region is critical for the structural integrity of the MLP.
20
21
22
23
24 All of the YbdZ variants, with the exception of D8A and I16A, had reduced levels in the absence
25
26 of the NRPS partner, showing that MLP stability can be influenced by the NRPS partner.
27
28
29 However, beyond influencing solubility, the EntF/YbdZ interactions are dynamic and the
30
31 functional interactions continue after folding. These data indicate that overall topology and
32
33 stability of the MLP/NRPS interface plays an important role for functional interactions. While
34
35
36
the MLP variants that are structurally compromised may be able to stabilize EntF (Fig. 5A),
37
38 topological incompatibilities between the MLP and NRPS result in functionally reduced EntF
39
40 (Table 1). However, the complex influence of the MLP and NRPS on the stability of one another
41
42
makes these systems difficult to parse apart using in vitro methods as both EntF and the YbdZ
43
44
45 variants likely have altered properties when overproduced in the absence of their partners. It is
46
47 also important to note that a caveat to our approach is that the substitution of an alanine for each
48
49 residue in most cases removes a significant component of the amino acid side chain. Such
50
51
52 changes may cause unwanted voids in the internal regions of the protein, impacting protein
53
54 stability, or will only identify residues with side chains that make specific interactions needed for
55
56
57
58
59 27
1
2
3 function NRPS/MLP interactions for those residues that are surface exposed. Even with the
4
5
6 limitations, this approach has been invaluable in providing significant insights into the key
7
8 residues needed for functional EntF/YbdZ interactions.
9
10
11
12
13
Throughout the study of NRPS enzymology, protein-protein interactions between the NRPS
14
15 components have been shown to be specialized and specific for their appropriate partners.23–27
16
17 This trend holds true for MLPs as well and is further supported by this structure-function
18
19
analysis. While some conserved residues (W27, W37 and P62) were found to be critical, the
20
21
22 majority of the residues we identified were not highly conserved across the MLP superfamily.
23
24 Understanding the specificity between MLP/NRPS components will be a significant challenge in
25
26 engineering NRPSs to produce hybrid natural products. Our data may indicate that rather than
27
28
29 target specific residues in the MLP to generate functional noncognate interactions, the generation
30
31 of chimeric MLPs containing critical regions of contact might be a useful strategy for
32
33 engineering noncognate MLPs that can interact with multiple NRPS partners. Alternatively, our
34
35
36
understanding of this specificity would be improved if we knew why certain NRPSs do not need
37
38 MLPs. The existence of MLP-independent NRPSs indicates that the role of the MLP can be
39
40 bypassed, yet the structural and biochemical data accumulated thus far do not explain why.
41
42
Therefore, directed evolution of an MLP-dependent NRPS to be soluble or active in the absence
43
44
45 of an MLP is a logical next step in understanding the physiological role of this superfamily and
46
47 overcoming the intricacy of MLP/NRPS dependence.
48
49
50
SUPPORTING INFORMATION
51
52
53
54 Modeling the location of YbdZ residues P6, D8, L17, W27, W37, I16, L53, P62 (Figure S1),
55 Modeling the location of YbdZ residues involved in forming or potentially influencing the
56
57
58
59 28
1
2
3 alanine pocket and the location of P62 in YbdZ and PA2412 (Figure S2), Immunoblotting to
4
detect in vivo levels of YbdZ (Figure S3), Assessment of in vivo complementation by YbdZ
5
6 variants (Figure S4), Representative data determining the Kd of EntF for YbdZ variants (Figure
7 S5), Representative data for determining the Km of EntF+YbdZ variants for L-Ser (Figure S6),
8 SDS-PAGE/Coomassie Blue staining to assess P6A or I16A co-purification with EntF (Figure
9 S7), List of primers used in this study (Table S1), List of strains used in this study (Table S2),
10 List of plasmids used in this study (Table S3).
11
12
13
14
15
16 AUTHOR INFORMATION
17
18
19 Corresponding Author
20
21 * Contact information for the author to whom correspondence should be addressed. Phone: (608)
22
23
24 263-9075 Email: michael.thomas@wisc.edu
25
26
27 Author Contributions
28
29
The manuscript was written through contributions of all authors. All authors have given approval
30
31
32 to the final version of the manuscript.
33
34
35 Funding Sources
36
37
38 This work was funded by the National Institutes of Health grant GM100346.
39
40
41 ABBREVIATIONS
42 A, adenylation, PCP, peptidyl carrier protein, C, condensation, NRPS, nonribosomal peptide
43 synthetase, MLP, MbtH-like protein, ENT, enterobactin, EDDHA, ethylenediamine-N,N’-bis(2-
44 hydroxyphenylacetic acid), TCEP, Tris-(2-carboxyethlyphosphine), IPTG, Isopropyl β-D-1-
45
46
thiogalactopyranoside, PAGE, polyacrylamide gel electrophoresis, TEV, tobacco etch virus,
47 DTT, dithiothreitol, CAS, Chrome azurol S, Ser-AVS, serine adenosine vinylsulfamide.
48
49
50
51
52
53
54 REFERENCES
55 (1) Felnagle, E. A., Barkei, J. J., Park, H., Podevels, A. M., McMahon, M. D., Drott, D. W., and
56 Thomas, M. G. (2010) MbtH-like proteins as integral components of bacterial nonribosomal
57
58
59 29
1
2
3 peptide synthetases. Biochemistry 49, 8815–8817.
4
(2) Zhang, W., Heemstra, J. R., Walsh, C. T., and Imker, H. J. (2010) Activation of the
5
6 pacidamycin PacL adenylation domain by MbtH-like proteins. Biochemistry 49, 9946–9947.
7 (3) Boll, B., Taubitz, T., and Heide, L. (2011) Role of MbtH-like proteins in the adenylation of
8 tyrosine during aminocoumarin and vancomycin biosynthesis. J. Biol. Chem. 286, 36281–36290.
9 (4) Baltz, R. H. (2011) Function of MbtH homologs in nonribosomal peptide biosynthesis and
10 applications in secondary metabolite discovery. J. Ind. Microbiol. Biotechnol. 38, 1747–60.
11 (5) Quadri, L. E., Sello, J., Keating, T. A., Weinreb, P. H., and Walsh, C. T. (1998) Identification
12
13
of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of
14 the virulence-conferring siderophore mycobactin. Chem. Biol. 5, 631–645.
15 (6) Reichert, J., Sakaitani, M., and Walsh, C. T. (1992) Characterization of EntF as a serine-
16 activating enzyme. Protein Sci. 1, 549–556.
17 (7) McMahon, M. D., Rush, J. S., and Thomas, M. G. (2012) Analyses of MbtB, MbtE, and
18 MbtF suggest revisions to the mycobactin biosynthesis pathway in Mycobacterium tuberculosis.
19
J. Bacteriol. 194, 2809–2818.
20
21 (8) Zolova, O. E., and Garneau-Tsodikova, S. (2012) Importance of the MbtH-like protein TioT
22 for production and activation of the thiocoraline adenylation domain of TioK. Medchemcomm 3,
23 950.
24 (9) Miller, B. R., Drake, E. J., Shi, C., Aldrich, C. C., and Gulick, A. M. (2016) Structures of a
25 nonribosomal peptide synthetase module bound to MbtH-like proteins support a highly dynamic
26 domain achitecture. J. Biol. Chem. 291, 22559–22571.
27
(10) Schomer, R. A., and Thomas, M. G. (2017) Characterization of the functional variance in
28
29 MbtH-like protein interactions with a nonribosomal peptide synthetase. Biochemistry 56, 5380–
30 5390.
31 (11) Imker, H., Krahn, D., Kaiser, M., and Walsh, C. T. (2010) N -Acylation during glidobactin
32 biosynthesis by the tridomain nonribosomal peptide. Chem. Biol. 17, 1077–1083.
33 (12) Buchko, G. W., Kim, C.-Y., Terwilliger, T. C., and Myler, P. J. (2011) Solution structure of
34 Rv2377c-founding member of the MbtH-like protein family. Tuberculosis. 90, 245–251.
35
36
(13) Drake, E. J., Cao, J., Qu, J., Shah, M. B., Straubinger, R. M., and Gulick, A. M. (2007) The
37 1.8 A crystal structure of PA2412, an MbtH-like protein from the pyoverdine cluster of
38 Pseudomonas aeruginosa. J. Biol. Chem. 282, 20425–34.
39 (14) Herbst, D. A., Boll, B., Zocher, G., Stehle, T., and Heide, L. (2013) Structural basis of the
40 interaction of MbtH-like proteins, putative regulators of nonribosomal peptide biosynthesis, with
41 adenylating enzymes. J. Biol. Chem. 288, 1991–2003.
42
(15) Drake, E. J., Miller, B. R., Shi, C., Tarrasch, J. T., Sundlov, J. A., Leigh Allen, C., Skiniotis,
43
44 G., Aldrich, C. C., and Gulick, A. M. (2016) Structures of two distinct conformations of holo-
45 non-ribosomal peptide synthetases. Nature 529, 235–238.
46 (16) Tarry, M. J., Haque, A. S., Bui, K. H., and Schmeing, T. M. (2017) X-Ray crystallography
47 and electron microscopy of cross- and multi module nonribosomal peptide synthetase proteins
48 reveal a flexible architecture. Structure. 25, 783–793.
49 (17) Mori, S., Pang, A. H., Lundy, T. A., Garzan, A., and Tsodikov, O. V. (2018) Structural basis
50
for backbone N-methylation by an interrupted adenylation domain. Nat. Chem. Biol. 14, 428–
51
52 430.
53 (18) Pettis, G. S., and Mcintosh, M. A. (1987) Molecular characterization of the Escherichia Coli
54 Enterobactin cistron entF and coupled cxpression of entF and the fes gene. 169, 4154–4162.
55 (19) Gehring, A. M., Mori, I., and Walsh, C. T. (1998) Reconstitution and characterization of the
56
57
58
59 30
1
2
3 Escherichia coli enterobactin synthetase. Biochemistry 2960, 2648–2659.
4
(20) Ehmann, D. E., Shaw-Reid, C. A., Losey, H. C., and Walsh, C. T. (2000) The EntF and
5
6 EntE adenylation domains of Escherichia coli enterobactin synthetase: Sequestration and
7 selectivity in acyl-AMP transfers to thiolation domain cosubstrates. PNAS 97, 2509–2514.
8 (21) Shaw-Reid, C. A., Kelleher, N. L., Losey, H. C., Gehring, A. M., Berg, C., and Walsh, C. T.
9 (1999) Assembly line enzymology by multimoldular nonribosomal peptide synthetases: the
10 thioesterase domain of E. coli EntF catalyzes both elongation and cyclolactonization. Chem.
11 Biol. 6, 385–400.
12
13
(22) Walsh, C. T., and Zhang, W. (2011) Chemical logic and enzymatic machinery for biological
14 assembly of peptidyl nucleoside antibiotics. ACS Chem. Biol. 6, 1000–1007.
15 (23) Lai, J. R., Fischbach, M. A., Liu, D. R., and Walsh, C. T. (2006) Localized protein
16 interaction surfaces on the EntB carrier protein revealed by combinatorial mutagenesis and
17 selection. J. Am. Chem. Soc. 128, 11002–11003.
18 (24) Frueh, D. P., Arthanari, H., Koglin, A., Vosburg, D. A., Bennett, E., Walsh, C. T., and
19
Wagner, G. (2008) Dynamic thiolation-thioesterase structure of a non-ribosomal peptide
20
21 synthetase. Nature 454, 903–906.
22 (25) Hur, G. H., Meier, J. L., Baskin, J., Codelli, J. A., Bertozzi, C. R., Marahiel, M. A., and
23 Burkart, M. D. (2009) Crosslinking studies of protein-protein interactions in nonribosomal
24 peptide biosynthesis. Chem. Biol. 16, 372–381.
25 (26) Jaremko, M. J., Lee, D. J., Patel, A., Winslow, V., Opella, S. J., Mccammon, J. A., and
26 Burkart, M. D. (2017) Manipulating protein−protein interactions in nonribosomal peptide
27
synthetase type II peptidyl carrier proteins. Biochemistry 56, 5269–5273.
28
29 (27) Liu, H., Gao, L., Han, J., Ma, Z., Lu, Z., Dai, C., Zhang, C., and Bie, X. (2016)
30 Biocombinatorial synthesis of novel lipopeptides by COM domain-mediated reprogramming of
31 the plipastatin NRPS complex. Front. Microbiol. 7, 1–8.
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59 31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30 For Table of Contents use only.
31
32
33
34 Alanine and serine scanning of YbdZ, an MbtH-like protein, reveals essential residues for functional
35 interactions with its nonribosomal peptide synthetase partner EntF.
36
37
Rebecca A. Schomer, Hyunjun Park, John J. Barkei, and Michael G. Thomas
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59 32
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59 33
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59

Schomer 2018

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Schomer 2018

Uploaded by

Copyright:

Available Formats

Subscriber access provided by TUFTS UNIV

is published by the American Chemical Society. 1155 Sixteenth Street N.W.,

You might also like